Harvard Bioscience (HBIO) Interest & Investment Income (2019 - 2026)
Harvard Bioscience (HBIO) reported Interest & Investment Income of -$1.7 million for Q1 2026, down 85.21% year-over-year from -$11.7 million in Q1 2025, and up 26.72% quarter-over-quarter from -$2.4 million in Q4 2025.
Harvard Bioscience (HBIO) Interest & Investment Income (2019 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 8 years of Interest & Investment Income data on file, last reported at -$1.7 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at -$1.7 million, down 85.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.8 million (down 57.15% YoY), and the FY2025 annual result was -$4.9 million, down 39.06% from the prior year.
- Interest & Investment Income climbed to -$1.7 million in Q1 2026 per HBIO's latest filing, from -$2.4 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at -$384000.0 in Q1 2022 and troughed at -$2.4 million in Q4 2025.
- A 5-year average of -$967705.9 and a median of -$882000.0 in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income tumbled 153.65% in 2023, then grew 22.9% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at -$900000.0 in 2022, then advanced by 11.78% to -$794000.0 in 2023, then slumped by 48.61% to -$1.2 million in 2024, then sank by 99.83% to -$2.4 million in 2025, then gained by 26.72% to -$1.7 million in 2026.
- Business Quant data shows HBIO's Interest & Investment Income at -$1.7 million in Q1 2026, -$2.4 million in Q4 2025, and -$966000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.73 Mn |
| Dec 31, 2025 | -2.36 Mn |
| Sep 30, 2025 | -966,000.00 |
| Jun 30, 2025 | -791,000.00 |
| Mar 31, 2025 | -933,000.00 |
| Dec 31, 2024 | -1.18 Mn |
| Sep 30, 2024 | -856,000.00 |
| Jun 30, 2024 | -749,000.00 |
| Mar 31, 2024 | -751,000.00 |
| Dec 31, 2023 | -794,000.00 |
| Sep 30, 2023 | -882,000.00 |
| Jun 30, 2023 | -941,000.00 |
| Mar 31, 2023 | -974,000.00 |
| Dec 31, 2022 | -900,000.00 |
| Sep 30, 2022 | -749,000.00 |
| Jun 30, 2022 | -515,000.00 |
| Mar 31, 2022 | -384,000.00 |
| Dec 31, 2021 | -379,000.00 |
| Sep 30, 2021 | -373,000.00 |
| Jun 30, 2021 | -377,000.00 |